← Back to Search

MRI Monitoring for Prostate Cancer (NA_00067284 Trial)

N/A
Recruiting
Led By Danny Song, M.D.
Research Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Histologically-confirmed prostate cancer
Plan to undergo external radiation treatment of prostate cancer
Must not have
Patients who have chronic kidney disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether using MRI to monitor tissue response during and after radiotherapy for prostate cancer is feasible, and if so, whether it can provide more information than simple anatomic information.

Who is the study for?
This trial is for men with confirmed prostate cancer who are planning to receive external radiation treatment. It's not suitable for those with a cardiac pacemaker, metal implants, chronic kidney disease, an inability to undergo MRI scans, or allergies to gadolinium-based contrast agents.
What is being tested?
The study is testing the use of advanced MRI techniques like MRS, DWI, and DCE during and after radiotherapy to monitor tissue response in prostate cancer patients. The goal is to see if these MRIs can provide early information on tumor recurrence and normal tissue damage.
What are the potential side effects?
There are generally no side effects associated directly with undergoing MRI imaging itself; however, there may be risks related to lying still for long periods during the scan or reactions in those allergic to contrast agents used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My prostate cancer diagnosis was confirmed through a tissue examination.
Select...
I am planning to receive external radiation for prostate cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have chronic kidney disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
MRI use to predict treatment response
Secondary study objectives
Evaluating MRI use to predict functional radiation treatment dose distribution

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MRI imagingExperimental Treatment1 Intervention
Use of MRI imaging in conjunction with standard radiation treatment

Find a Location

Who is running the clinical trial?

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
570 Previous Clinical Trials
33,210 Total Patients Enrolled
57 Trials studying Prostate Cancer
3,408 Patients Enrolled for Prostate Cancer
Danny Song, M.D.Principal InvestigatorThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
3 Previous Clinical Trials
56 Total Patients Enrolled
2 Trials studying Prostate Cancer
50 Patients Enrolled for Prostate Cancer

Media Library

MRI imaging Clinical Trial Eligibility Overview. Trial Name: NCT01607008 — N/A
Prostate Cancer Research Study Groups: MRI imaging
Prostate Cancer Clinical Trial 2023: MRI imaging Highlights & Side Effects. Trial Name: NCT01607008 — N/A
MRI imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT01607008 — N/A
~2 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top